9,12,15-Octadecatrienoic acid

Details

Top
Internal ID 3e8e5249-46b1-4258-9c2d-61e4294f2801
Taxonomy Lipids and lipid-like molecules > Fatty Acyls > Lineolic acids and derivatives
IUPAC Name octadeca-9,12,15-trienoic acid
SMILES (Canonical) CCC=CCC=CCC=CCCCCCCCC(=O)O
SMILES (Isomeric) CCC=CCC=CCC=CCCCCCCCC(=O)O
InChI InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)
InChI Key DTOSIQBPPRVQHS-UHFFFAOYSA-N
Popularity 2,823 references in papers

Physical and Chemical Properties

Top
Molecular Formula C18H30O2
Molecular Weight 278.40 g/mol
Exact Mass 278.224580195 g/mol
Topological Polar Surface Area (TPSA) 37.30 Ų
XlogP 5.90
Atomic LogP (AlogP) 5.66
H-Bond Acceptor 1
H-Bond Donor 1
Rotatable Bonds 13

Synonyms

Top
9,12,15-Octadecatrienoic acid, (9Z,12Z,15Z)-
|A-Lnn
CBiol_001952
KBioGR_000096
KBioSS_000096
9,12,15-octadecatrienic acid
9,12,15-octadectrienoic acid
CHEMBL3560296
DTXSID7075058
KBio2_000096
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of 9,12,15-Octadecatrienoic acid

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9923 99.23%
Caco-2 + 0.6071 60.71%
Blood Brain Barrier + 0.8000 80.00%
Human oral bioavailability - 0.5714 57.14%
Subcellular localzation Plasma membrane 0.5044 50.44%
OATP2B1 inhibitior - 0.8530 85.30%
OATP1B1 inhibitior - 0.4580 45.80%
OATP1B3 inhibitior - 0.3406 34.06%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.9500 95.00%
BSEP inhibitior + 0.5594 55.94%
P-glycoprotein inhibitior - 0.8342 83.42%
P-glycoprotein substrate - 0.9574 95.74%
CYP3A4 substrate - 0.6597 65.97%
CYP2C9 substrate + 0.6276 62.76%
CYP2D6 substrate - 0.8766 87.66%
CYP3A4 inhibition - 0.9465 94.65%
CYP2C9 inhibition - 0.8798 87.98%
CYP2C19 inhibition - 0.9638 96.38%
CYP2D6 inhibition - 0.9631 96.31%
CYP1A2 inhibition + 0.6915 69.15%
CYP2C8 inhibition - 0.9243 92.43%
CYP inhibitory promiscuity - 0.9426 94.26%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.6935 69.35%
Carcinogenicity (trinary) Non-required 0.6373 63.73%
Eye corrosion + 0.9371 93.71%
Eye irritation + 0.8357 83.57%
Skin irritation + 0.7676 76.76%
Skin corrosion - 0.6260 62.60%
Ames mutagenesis - 0.8800 88.00%
Human Ether-a-go-go-Related Gene inhibition - 0.3603 36.03%
Micronuclear - 0.9900 99.00%
Hepatotoxicity - 0.6125 61.25%
skin sensitisation + 0.8470 84.70%
Respiratory toxicity + 0.7444 74.44%
Reproductive toxicity - 0.6531 65.31%
Mitochondrial toxicity + 0.7875 78.75%
Nephrotoxicity - 0.8766 87.66%
Acute Oral Toxicity (c) IV 0.6387 63.87%
Estrogen receptor binding + 0.5761 57.61%
Androgen receptor binding - 0.8917 89.17%
Thyroid receptor binding + 0.6398 63.98%
Glucocorticoid receptor binding - 0.7344 73.44%
Aromatase binding - 0.4910 49.10%
PPAR gamma + 0.8890 88.90%
Honey bee toxicity - 0.9918 99.18%
Biodegradation + 0.6750 67.50%
Crustacea aquatic toxicity + 0.5200 52.00%
Fish aquatic toxicity + 0.8175 81.75%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL2903 P16050 Arachidonate 15-lipoxygenase 125.9 nM
Potency
via Super-PRED
CHEMBL239 Q07869 Peroxisome proliferator-activated receptor alpha 7.9 nM
Kd
via Super-PRED

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3060 Q9Y345 Glycine transporter 2 96.97% 99.17%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.31% 96.09%
CHEMBL2581 P07339 Cathepsin D 94.53% 98.95%
CHEMBL1781 P11387 DNA topoisomerase I 90.68% 97.00%
CHEMBL221 P23219 Cyclooxygenase-1 89.12% 90.17%

Cross-Links

Top
PubChem 860
NPASS NPC1813
LOTUS LTS0216950
wikiData Q27164304